Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1245.50

-24.30 (-1.91%)

< Home < Back

USFDA completes audit at Dr. Reddy’s API Hyderabad plant

Date: 16-03-2018

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy’s Laboratories’ API Hyderabad plant I at Jinnaram Mandal, Medak District, Telangana on March 16, 2018. USFDA has issued a Form 483 with four observations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.